Background The time course and rate of recovery of myocardial dysfunction i
n association with Kawasaki disease inl response to intravenous gamma-globu
lin is unknown and may provide mechanistic clues.
Methods and Results The acute changes in myocardial contractility in 25 pat
ients with Kawasaki disease were evaluated by noninvasive stress-shortening
and stress-velocity analysis. Echocardiograms were performed before and th
en daily for 4 days during which the patients received gamma-globulin 1.6 t
o2 g/kg, Before treatment, contractility was abnormally low (<2 SD) in 14 p
atients (56%). Contractility increased significantly (SD-increase) in 17 (6
8%), including 13 of 14 with depressed contractility and 4 whose initial co
ntractility fell within normal limits. Of the 14 patients with depressed co
ntractility, 8 (57%) normalized within 24 hours and a further 5 (35.7%) nor
malized within 6 months. A clinical response to treatment (fall in C-reacti
ve protein by 50% and/or resolution of fever within 4 days) was seen in 22
patients (88%). Contractility increased in 17 of the 22 clinical responders
and was normal before therapy in the other 5. The 3 patients who did not r
espond clinically also had no change in contractility with gamma-globulin t
herapy. Long-term (more than 12 months) follow-up was available in 19 patie
nts. All patients had normal contractility at late follow-up.
Conclusions More than half the patients with Kawasaki disease have abnormal
contractility at presentation. Myocardial response to gamma-globulin thera
py is associated with rapid improvement in myocardial mechanics, with a hig
h concordance between the clinical and myocardial response to therapy. The
speed of recovery suggests that depressed contractility in patients with Ka
wasaki disease is caused by a rapidly reversible process such as circulatin
g toxins or activated cytokines, long-term outcome is good even in those pa
tients with slow recovery of myocardial function.